DM
GHDX

Deerfield Management’s Genomic Health, Inc. GHDX Stock Holding History

Deerfield Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-809,432
Closed -$28.5M – 122
2015
Q4 		$28.5M Sell
809,432
-284,084
-26% -$7.61M 1.15% 34
2015
Q3 		$23.1M Sell
1,093,516
-89,484
-8% -$2.31M 0.9% 44
2015
Q2 		$32.9M Buy
+1,183,000
New +$33.4M 1.1% 31

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management's GHDX Position: Q1 2016 in Review

Deerfield Management sold out of Genomic Health, Inc. (GHDX) in Q1 2016, closing a stake of 809,432 shares — an estimated $28.5M sold.

Deerfield Management first reported a position in GHDX in Q2 2015 and held it in 3 quarters. The position peaked at $32.9M in Q2 2015. 127 funds tracked by Wall St. Rank hold GHDX as of Q1 2016.

  • Deerfield Management reported no remaining Genomic Health, Inc. position as of Q1 2016 after selling out during the quarter.
  • Deerfield Management sold 809,432 Genomic Health, Inc. shares in Q1 2016, an estimated $28.5M.
  • Deerfield Management first reported a position in Genomic Health, Inc. in Q2 2015 and held it in 3 quarters.
  • Deerfield Management's Genomic Health, Inc. position peaked at $32.9M in Q2 2015.
  • 127 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2016.

Based on Deerfield Management's 13F filing for Q1 2016, filed 16 May 2016.